Designing a targeted treatment for aggressive lung cancer

Associate Professor Thomas Cox, The Garvan Institute of Medical Research
Associate Professor Thomas Cox and his team have identified a molecule in the lung tissue matrix called ‘Collagen IV’, which helps to control the behaviour of lung cancer cells. By targeting Collagen IV, they can slow down tumour growth, reduce cancer spread around the body, and improve chemotherapy efficiency.
In this project, the team will use advanced cell-imaging technologies and pre-clinical lung cancer testing to develop Collagen IV biomarkers and targeted treatments. Their ultimate goal is to design a new personalised treatment approach for aggressive lung cancer.
Read more here - www.cancercoun...